Saidal
| Company type | Joint stock company |
|---|---|
| Industry | Pharmaceutical |
| Founded | 1982 |
| Headquarters | Algiers , Algeria |
Area served | Algeria, Ivory Coast, Gabon, Senegal, Cameroon, Mali, Democratic Republic of the Congo, Republic of the Congo, Niger, Togo, Benin, Guinea-Bissau, Chad, Mauritania |
Key people | Wassim Kouidri (CEO) |
| Products | Pharmaceuticals |
Saidal Group (, ) is a pharmaceutical enterprise based in Algeria, founded in 1982. It stands as the largest pharmaceutical organization within Algeria and ranks among the leading companies across Africa.
The company distributes its products to numerous African countries, such as Ivory Coast, Gabon, Senegal, Cameroon, Mali, Democratic Republic of the Congo, Republic of the Congo, Niger, Togo, Benin, Guinea-Bissau, Chad, and Mauritania.
History
Saidal was created in April 1982 following the reorganization of the Algerian Central Pharmacy and adopted its present name three years later, in 1985.
In 1989, Saidal transitioned into an economic public company and was one of the pioneering national entities to convert into a joint stock company by 1993. By 1997, it had developed into an industrial conglomerate that included subsidiaries such as Biotic, Pharmal, and Antibiotical.
In March 2022, Saidal inaugurated its inaugural bioequivalence center named "Equival," which strengthens its pharmaceutical research and development capabilities.
Company management
The succession of Saidal's chief executives is as follows:
- Ali Aoun (1995–2008)
- Rachid Zahouani (2008–?)
- Boumediene Derkaoui (2010–2015)
- Mohamed Hammouche (2015–2016)
- Yacine Tounsi (2016–3 January 2018)
- Mohamed Nouas (3 January 2018–11 February 2020)
- Fatouma Akacem (11 February 2020–10 April 2023)
- Wassim Kouidri (10 April 2023–present)